Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.

In order to simulate the natural long term parasitisms which may occur in mammals infected with Leishmania, cutaneous leishmaniases due to Leishmania major or Leishmania amazonensis were induced using a model based on the inoculation of 10-1000 metacyclic promastigotes into the ear dermis of BALB/c mice. The final outcome of these parasitisms was dependent upon the number of inoculated parasites. Only some of the mice inoculated with ten parasites displayed cutaneous lesions, whereas most mice infected with 100 metacyclics and all mice infected with 1000 metacyclics developed progressive lesions. We found, using the latter experimental conditions, that the onset of the pathology was associated with: (a) parasite multiplication in the inoculation site and the draining lymph node correlating with an increase of the lymph node cell number, especially in L. major-infected mice; and (b) the detection of lymph node cells, at least in part CD4(+) T lymphocytes, able to produce high levels of interferon-gamma, interleukin (IL)-4, IL-10 and IL-13. Thereafter, mice infected by L. major harboured few parasites in the ear and had a 100-fold reduction in lymph node parasite load between 23 and 40 weeks post-inoculation. In contrast, the parasite loads of L. amazonensis-infected mice remained stable in the ear and increased in nodes during the same period of time. Only L. major-infected mice that exhibited cutaneous lesions in the primary site were resistant to the re-inoculation of 1000 metacyclic promastigotes, whereas all L. amazonensis-primary infected mice remained susceptible to a second homologous challenge. These results are the first to document that a status of resistance to re-infection, referred to concomitant immunity, is coupled to the development of primary progressive lesions in L. major-infected BALB/c mice. Such a protective status is absent in L. amazonensis-infected BALB/c mice.

[1]  R. Locksley,et al.  The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.

[2]  T. Curiel,et al.  Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. , 1998, Journal of immunology.

[3]  Y. Belkaid,et al.  Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. , 2000, Science.

[4]  J. Blackwell,et al.  IL-13 Is a Susceptibility Factor for Leishmania major Infection , 2000, The Journal of Immunology.

[5]  Y. Belkaid,et al.  The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. , 1996, Journal of immunology.

[6]  D. Sacks,et al.  Metacyclogenesis in Leishmania promastigotes. , 1989, Experimental parasitology.

[7]  C. Fréhel,et al.  Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages , 2001, Parasitology.

[8]  M. Lohoff,et al.  Polyclonal B-cell stimulation by L3T4+ T cells in experimental leishmaniasis , 1988, Infection and immunity.

[9]  H. Bielefeldt-Ohmann,et al.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. , 1992, Science.

[10]  Hai Qi,et al.  Leishmania amazonensis-Dendritic Cell Interactions In Vitro and the Priming of Parasite-Specific CD4+ T Cells In Vivo1 , 2001, The Journal of Immunology.

[11]  G. Milon,et al.  The Levels and Patterns of Cytokines Produced by CD4 T Lymphocytes of BALB/c Mice Infected with Leishmania major by Inoculation into the Ear Dermis Depend on the Infectiousness and Size of the Inoculum , 2003, Infection and Immunity.

[12]  Douglas E. Jones,et al.  Early Enhanced Th1 Response after Leishmania amazonensis Infection of C57BL/6 Interleukin-10-Deficient Mice Does Not Lead to Resolution of Infection , 2002, Infection and Immunity.

[13]  M. Röllinghoff,et al.  Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major. , 1993, The Journal of infectious diseases.

[14]  N. Glaichenhaus,et al.  Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites , 1999, European journal of immunology.

[15]  C. Bogdan,et al.  Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major , 1994, The Journal of experimental medicine.

[16]  M. Meltzer,et al.  Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection. , 1988, Journal of immunology.

[17]  R. Locksley,et al.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets , 1989, The Journal of experimental medicine.

[18]  R. Rerko,et al.  Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.

[19]  R. Locksley,et al.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Scott,et al.  Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis , 1993, Infection and immunity.

[21]  P. Bretscher,et al.  Immune Elimination of Leishmania major in Mice: Implications for Immune Memory, Vaccination, and Reactivation Disease1 , 2001, The Journal of Immunology.

[22]  Y. Belkaid,et al.  The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.

[23]  C. Auriault,et al.  IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection. , 2002, Parasitology international.

[24]  D. Biegel,et al.  Leishmania mexicana: temperature sensitivity of isolated amastigotes and of amastigotes infecting macrophages in culture. , 1983, Experimental parasitology.

[25]  Y. Belkaid,et al.  Transient inducible events in different tissues: in situ studies in the context of the development and expression of the immune responses to intracellular pathogens. , 1994, Immunobiology.

[26]  W A Buurman,et al.  Limiting dilution assays. Experimental design and statistical analysis. , 1987, Journal of immunological methods.

[27]  D. Sacks,et al.  The immunology of susceptibility and resistance to Leishmania major in mice , 2002, Nature Reviews Immunology.

[28]  C. Taswell,et al.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.

[29]  P. Bretscher,et al.  Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite , 1998, European journal of immunology.

[30]  É. Prina,et al.  The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages. , 1998, Trends in microbiology.

[31]  A. Sher,et al.  Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. , 1985, Journal of immunology.

[32]  Douglas E. Jones,et al.  IL-4-Independent Inhibition of IL-12 Responsiveness During Leishmania amazonensis Infection1 , 2000, The Journal of Immunology.

[33]  M. Roncarolo,et al.  A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. , 1999, Journal of immunology.

[34]  R. Schaub,et al.  Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.

[35]  J. Shaw,et al.  Leishmaniasis in Brazil: I. Observations on enzootic rodent leishmaniasis--incrimination of Lutzomyia flaviscutellata (Mangabeira) as the vector in the Lower Amazonian Basin. , 1968, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[36]  J. Sun,et al.  Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. , 1997, Journal of immunology.

[37]  T. Aoki,et al.  Inhibition of Fas-mediated apoptosis by Trypanosoma cruzi infection. , 2000, Biochimica et biophysica acta.

[38]  T. Springer,et al.  A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. , 1981, Journal of immunology.

[39]  P. Bretscher,et al.  Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge , 1996, European journal of immunology.

[40]  J. Sun,et al.  Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. , 1996, Immunity.

[41]  W. Paul,et al.  IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. , 1999, Journal of immunology.

[42]  Y. Belkaid,et al.  A Natural Model of Leishmania major Infection Reveals a Prolonged “Silent” Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity , 2000, The Journal of Immunology.

[43]  A. Ismail,et al.  Necrotizing and suppurative lymphadenitis in Leishmania major infections , 1996, Tropical medicine & international health : TM & IH.

[44]  Y. Schlein,et al.  The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. , 1986, The American journal of tropical medicine and hygiene.

[45]  R. L. Berens,et al.  An easily prepared defined medium for cultivation of Leishmania donovani promastigotes. , 1978, The Journal of parasitology.

[46]  Doherty Tm,et al.  Leishmania major:Effect of Infectious Dose on T Cell Subset Development in BALB/c Mice , 1996 .

[47]  H. Karasuyama,et al.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.

[48]  K. Moore,et al.  Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. , 1994, Journal of immunology.

[49]  D. Sacks,et al.  Thermosensitivity patterns of Old vs. New World cutaneous strains of Leishmania growing within mouse peritoneal macrophages in vitro. , 1983, The American journal of tropical medicine and hygiene.

[50]  F. Weinbaum,et al.  Leishmania tropica: association of a B-cell mitogen with hypergammaglobulinemia in mice. , 1982, Experimental parasitology.

[51]  D. Mosser,et al.  The Role of IL-10 in Promoting Disease Progression in Leishmaniasis1 , 2001, The Journal of Immunology.

[52]  A. Ryter,et al.  Megasomes as the targets of leucine methyl ester in Leishmania amazonensis amastigotes , 1989, Parasitology.

[53]  J. Shaw,et al.  Leishmaniasis in Brazil. V. Studies on the epidemiology of cutaneous leishmaniasis in Mato Grosso State, and observations on two distinct strains of Leishmania isolated from man and forest animls. , 1970, Transactions of the Royal Society of Tropical Medicine and Hygiene.